Kallinich et al., 2007 - Google Patents
T-cell co-stimulatory molecules: their role in allergic immune reactionsKallinich et al., 2007
View PDF- Document ID
- 4943649049172054825
- Author
- Kallinich T
- Beier K
- Wahn U
- Stock P
- Hamelmann E
- Publication year
- Publication venue
- European Respiratory Journal
External Links
Snippet
The development of allergic diseases, such as allergic asthma, depends upon the initiation and maintenance of T-helper cell type-2-skewed allergen-specific immune reactions. Although it is clear that susceptibility to this process is under genetic and environmental …
- 210000001744 T-Lymphocytes 0 title abstract description 54
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kallinich et al. | T-cell co-stimulatory molecules: their role in allergic immune reactions | |
| Riffo-Vasquez et al. | Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation | |
| Soroosh et al. | Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations | |
| Pöllinger et al. | Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans | |
| O’Sullivan et al. | IL-1β breaks tolerance through expansion of CD25+ effector T cells | |
| Meylan et al. | The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases | |
| Qamar et al. | The hyper IgM syndromes | |
| Miga et al. | Dendritic cell longevity and T cell persistence is controlled by CD154‐CD40 interactions | |
| Wang et al. | The role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses | |
| Katsifis et al. | T lymphocytes in Sjögren’s syndrome: contributors to and regulators of pathophysiology | |
| Tipping et al. | T cells in crescentic glomerulonephritis | |
| Vukmanovic-Stejic et al. | Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes | |
| Oflazoglu et al. | Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases | |
| Villegas et al. | Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii | |
| Okamoto et al. | IL-18 prevents the development of chronic graft-versus-host disease in mice | |
| Chen et al. | CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma | |
| Summers-deLuca et al. | Expression of lymphotoxin-αβ on antigen-specific T cells is required for DC function | |
| TW200539890A (en) | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function | |
| Busch et al. | Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis | |
| Chatzidakis et al. | T cells as sources and targets of TNF: implications for immunity and autoimmunity | |
| Möttönen et al. | Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells. | |
| Fukushima et al. | Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice | |
| Liu et al. | The role of co-signaling molecules in psoriasis and their implications for targeted treatment | |
| Riffo-Vasquez et al. | Cytokines in airway inflammation | |
| Wang et al. | Essential lymphocyte function associated 1 (LFA-1): intercellular adhesion molecule interactions for T cell–mediated B cell apoptosis by Fas/APO-1/CD95 |